SEK316.40
0.32% today
Stockholm, Apr 03, 05:30 pm CET
ISIN
SE0009858152
Symbol
BONEX
Sector

Bonesupport Holding AB Stock price

SEK316.40
-64.60 16.96% 1M
+14.40 4.77% 6M
-70.40 18.20% YTD
+90.20 39.88% 1Y
+268.80 564.71% 3Y
+287.70 1,002.44% 5Y
+284.40 888.75% 10Y
Stockholm, Closing price Thu, Apr 03 2025
-1.00 0.32%
ISIN
SE0009858152
Symbol
BONEX
Sector

Key metrics

Market capitalization SEK20.90b
Enterprise Value SEK20.69b
P/E (TTM) P/E ratio 155.96
EV/FCF (TTM) EV/FCF 322.45
EV/Sales (TTM) EV/Sales 23.02
P/S ratio (TTM) P/S ratio 23.26
P/B ratio (TTM) P/B ratio 28.74
Revenue growth (TTM) Revenue growth 52.05%
Revenue (TTM) Revenue SEK898.73m
EBIT (operating result TTM) EBIT SEK146.91m
Free Cash Flow (TTM) Free Cash Flow SEK64.17m
Cash position SEK227.00m
EPS (TTM) EPS SEK2.04
P/E forward 76.85
P/S forward 16.16
EV/Sales forward 15.99
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Bonesupport Holding AB forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Bonesupport Holding AB forecast:

Buy
100%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
899 899
52% 52%
100%
- Direct Costs 66 66
33% 33%
7%
832 832
54% 54%
93%
- Selling and Administrative Expenses 609 609
32% 32%
68%
- Research and Development Expense 76 76
33% 33%
8%
154 154
394% 394%
17%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 147 147
562% 562%
16%
Net Profit 134 134
45% 45%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Emil Billbäck
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today